Randomized, Double-blind, Placebo-controlled Cannabis Extract x Placebo for Cocaine Addicts
Status:
Recruiting
Trial end date:
2025-10-23
Target enrollment:
Participant gender:
Summary
2.1. General To evaluate the efficacy and safety of a Cannabis sativa extract (CBD
(Cannabidiol) + up to 0.3% THC (Delta-9-tetrahydrocannabinol)), compared to placebo, in the
treatment of cocaine/crack use disorder.
2.2. Specifics
- Compare the amount and frequency of cocaine use between the group treated with Cannabis
sativa extract and the placebo group
- Compare adherence to treatment between the group treated with Cannabis sativa extract
and the placebo group
- Evaluate the prevalence and intensity of depressive and anxious symptoms in patients
using Cannabis sativa extract compared to patients using placebo
- Evaluate the incidence and severity of side effects in the active group compared to
placebo.